General
Preferred name
selegiline
Synonyms
SELEGILINE HYDROCHLORIDE ()
(R)-(-)-Deprenyl hydrochloride ()
R-(-)-Deprenyl hydrochloride ()
Zelapar ()
NSC-759259 ()
Vivapryl ()
Centrapryl 10 ()
Centrapryl 5 ()
Eldepryl ()
Stilline 5 ()
Selegiline HCl ()
Ensam ()
Stilline 10 ()
L-Deprenyl ()
L-selegiline ()
EMSAM ()
Selegilina ()
R-(-)-Deprenyl (hydrochloride) ()
L-deprenyl-D2 C-11 ()
P&D ID
PD013116
CAS
14611-51-9
102741-42-4
14611-52-0
Tags
available
covalent binder
drug
drug candidate
Approved by
FDA
First approval
1989
Drug indication
Parkinson disease
Nicotine dependence
Major depressive disorder
Chemotherapy-induced nausea
cannabis dependence
Motor symptoms
Skin imperfections
Drug Status
approved
experimental
vet_approved
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Marketed formulations may contain (PubChem CID 26758). (GtoPdb)
DESCRIPTION Selegilinel is a selective, reversible inhibitor of monoamine oxide. In addition to finding use against depression, selegiline provides neuroprotection which may be relevant to Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and stroke. (Enamine Bioactive Compounds)
DESCRIPTION Adenylyl cyclase activator (Tocris Bioactive Compound Library)
Compound Sets
29
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CovalentInDB
Drug Repurposing Hub
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Tocris Bioactive Compound Library
External IDs
366
Properties
(calculated by RDKit )
Molecular Weight
187.14
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
0
Rotatable Bonds
4
Ring Count
1
Aromatic Ring Count
1
cLogP
2.18
TPSA
3.24
Fraction CSP3
0.38
Chiral centers
1.0
Largest ring
6.0
QED
0.65
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Primary Target
Monoamine Oxidases
MOA
MAO
Inhibitor
MAO-B Inhibitors
monoamine oxidase inhibitor
Member status
virtual
Indication
Parkinson's Disease
Target
MAOA, MAOB
MAO-B inhibitor
Therapeutic Class
Neurology Agents
Source data